Page 142 - 南京医科大学学报自然科学版
P. 142

第44卷第1期
               ·136 ·                            南 京    医 科 大 学 学         报                        2024年1月


                  the tumor microenvironment[J]. Trends Cancer,2022,8  latory T⁃cell generation[J]. Nature,2013,504(7480):
                  (11):901-914                                       451-455
             [25] JIN C,LAGOUDAS G K,ZHAO C,et al. Commensal mi⁃  [39] ZUO T,ZHANG F,LUI G C Y,et al. Alterations in gut
                   crobiota promote lung cancer development via gamma del⁃  microbiota of patients with COVID⁃19 during time of hos⁃
                   ta T cells[J]. Cell,2019,176(5):998-1013          pitalization[J]. Gastroenterology,2020,159(3):944-
             [26] QIAN X,ZHANG H Y,LI Q L,et al. Integrated microbi⁃  955
                   ome,metabolome,and proteome analysis identifies a nov⁃  [40] LI W,ZHU Y,LIAO Q,et al. Characterization of gut mi⁃
                   el interplay among commensal bacteria,metabolites and  crobiota in children with pulmonary tuberculosis[J].
                   candidate targets in non⁃small cell lung cancer[J]. Clin  BMC Pediatr,2019,19(1):445
                   Transl Med,2022,12(6):e947                   [41] SINGH N,GURAV A,SIVAPRAKASAM S,et al. Activa⁃
             [27] ZOU S M,FANG L K,LEE M H. Dysbiosis of gut micro⁃  tion of Gpr109a,receptor for niacin and the commensal
                   biota in promoting the development of colorectal cancer  metabolite butyrate,suppresses colonic inflammation and
                  [J].Gastroenterol Rep,2018,6(1):1-12               carcinogenesis[J]. Immunity,2014,40(1):128-139
             [28] KRAUTKRAMER K A,FAN J,BÄCKHED F. Gut micro⁃   [42] BLANDER J M,LONGMAN R S,ILIEV I D,et al. Regu⁃
                   bial metabolites as multi⁃kingdom intermediates[J]. Nat  lation of inflammation by microbiota interactions with the
                   Rev Microbiol,2021,19(2):77-94                    host[J]. Nat Immunol,2017,18(8):851-860
             [29] ROOKS M G,GARRETT W S. Gut microbiota,metabo⁃  [43] TANOUE T,MORITA S,PLICHTA D R,et al. A defined
                   lites and host immunity[J]. Nat Rev Immunol,2016,16  commensal consortium elicits CD8 T cells and anti⁃cancer
                  (6):341-352                                        immunity[J]. Nature,2019,565(7741):600-605
             [30] LOUIS P,HOLD G L,FLINT H J. The gut microbiota,  [44] WU Y,BISWAS D,USAITE I,et al. A local human Vδ1
                   bacterial metabolites and colorectal cancer[J]. Nat Rev  T cell population is associated with survival in non⁃small⁃
                   Microbiol,2014,12(10):661-672                     cell lung cancer[J]. Nat Cancer,2022,3(6):696-709
             [31] NGUYEN D X,CHIANG A C,ZHANG X H F,et al.      [45] ZHUANG H,CHENG L,WANG Y,et al. Dysbiosis of the
                   WNT/TCF signaling through LEF1 and HOXB9 mediates  gut microbiome in lung cancer[J]. Front Cell Infect Mi⁃
                   lung adenocarcinoma metastasis[J]. Cell,2009,138(1):  crobiol,2019,9:112
                   51-62                                        [46] ZHANG W Q,ZHAO S K,LUO J W,et al. Alterations of
             [32] GOPALAKRISHNAN V,HELMINK B A,SPENCER C             fecal bacterial communities in patients with lung cancer
                   N,et al. The influence of the gut microbiome on cancer,  [J]. Am J Transl Res,2018,10(10):3171-3185
                   immunity,and cancer immunotherapy[J]. Cancer Cell,  [47] ZHAO F,AN R,WANG L Q,et al. Specific gut microbi⁃
                   2018,33(4):570-580                                ome and serum metabolome changes in lung cancer pa⁃
             [33] ZHAO Y,JOHNSON W E. Exploring host⁃microbe inter⁃  tients[J]. Front Cell Infect Microbiol,2021,11:725284
                   actions in lung cancer[J]. Am J Respir Crit Care Med,  [48] IIDA N,DZUTSEV A,STEWART C A,et al. Commensal
                   2018,198(9):1116-1118                             bacteria control cancer response to therapy by modulating
             [34] SCHIRMER M,SMEEKENS S P,VLAMAKIS H,et al.          the tumor microenvironment[J]. Science,2013,342
                   Linking the human gut microbiome to inflammatory cyto⁃  (6161):967-970
                   kine production capacity[J]. Cell,2016,167(7):1897  [49] MCQUADE J L,DANIEL C R,HELMINK B A,et al.
             [35] BELLONE M,BREVI A,HUBER S. Microbiota ⁃ pro⁃       Modulating the microbiome to improve therapeutic re⁃
                   pelled T helper 17 cells in inflammatory diseases and  sponse in cancer[J]. Lancet Oncol,2019,20(2):e77-
                   cancer[J]. Microbiol Mol Biol Rev,2020,84(2):     e91
                   e00064-e00019                                [50] 印  滇,杨    莉,王以浪,等. 非小细胞肺癌患者化疗前
             [36] JAIN T,SHARMA P,ARE A C,et al. New insights into   后肠道微生态菌群多样性变化及其与预后的相关性
                   the cancer⁃microbiome⁃immune axis:decrypting a decade  [J]. 贵州医科大学学报,2022,47(4):492-496
                   of discoveries[J]. Front Immunol,2021,12:622064  [51] ZHANG M,LIU D,ZHOU H,et al. Intestinal flora charac⁃
             [37] CHEN F,STAPPENBECK T S. Microbiome control of in⁃  teristics of advanced non⁃small cell lung cancer in China
                   nate reactivity[J]. Curr Opin Immunol,2019,56:107-  and their role in chemotherapy based on metagenomics:a
                   113                                               prospective exploratory cohort study[J]. Thorac Cancer,
             [38] ARPAIA N,CAMPBELL C,FAN X Y,et al. Metabolites     2021,12(24):3293-3303
                   produced by commensal bacteria promote peripheral regu⁃  [52]LOMAN B R,JORDAN K R,HAYNES B,et al. Chemo⁃
   137   138   139   140   141   142   143   144   145   146   147